Golden
LoginSign Up
Leo Cancer Care

Leo Cancer Care

Leo Cancer Care is a company developing upright radiotherapy solutions based on research from MD Anderson Cancer Centre. This research indicates better treatment plan results for 71% of typical patients treated in the upright position.

Overview

Leo Cancer Care is developing upright radiotherapy devices. They believe it is clinically advantageous to treat patients upright. The devices may also reduce costs and machine size in the X-Ray market and the Proton market.

Technology

Leo Cancer Care is developing a full radiotherapy treatment device, Ruby, to treat cancer patients. Current industry practice is to position a patient horizontally on their back and to rotate a six tonne machine around them to deliver radiation from different angles to sub-millimetre accuracy.

Research from the MD Anderson Cancer Centre in Houston has shown that treatment efficacy is improved by treating patients in the upright position rather than horizontally. The Leo Cancer Care engineering team has also demonstrated that by keeping the radiation fixed and instead rotating the patient, the size and cost associated with treatments can be reduced by a factor of two.

History

Leo Cancer Care (formerly Nano-X) was founded in 2014 in Sydney, Australia. It was founded based on research from the MD Anderson Cancer Centre in Houston Texas.

Having completed 2 years of product development to an ISO 13485 quality management system, Leo Cancer Care is relocating the the United States to raise funds and finish the remainder of the product development.

Fundraising

In 2016, Leo Cancer Care received $2.5M dollars in non-dilutive government grant funding after winning the New South Wales Medical Device Fund.

Timeline

First Detailed Engineering Design Phase Complete

In June 2018, the first detailed design phase was closed off resulting in a full drawing pack ready for prototype manufacture.

First Formative Evaluation User Testing Completed

In October 2017, a full workflow formative evaluation was completed at the Nelune Comprehensive Cancer Centre in Sydney.

Leo Cancer Care Establishes Quality Management System

In 2017, the Quality Management System was established within which all product development has been completed.

Leo Cancer Care Wins New South Wales Medical Device Fund

In 2016, Leo Cancer Care was the recipient of a $2.5M non-dilutive government grant from New South Wales Health.

People

Name
Role
Related Golden topics

Ilana Feain

Director

Mark Strangeman

Chief Engineer

Rock Mackie

Director

Stephen Towe

CEO

Val Theisz

Head of Regulatory Affairs

Further reading

Title
Author
Link
Type

Reassessment of the Necessity of the Proton Gantry: Analysis of Beam Orientations From 4332 Treatments at the Massachusetts General Hospital Proton Center Over the Past 10 Years

Susu Yan, Hsiao-Ming Lu, Jay Flanz, Judith Adams, Alexei Trofimov, Thomas Bortfeld

Journal

Reproducibility of patient setup in the seated treatment position: A novel treatment chair design. - PubMed - NCBI

McCarroll RE , et al.

Web

SU-E-T-359: Patients Could (and Should) Be Treated in An Upright Position

L Court, J Yang, D Fullen, N Han, J Ko, S Mason, K Nguyen, S Stein, X Fave, M Hsieh, S Kuruvila, E Hillebrandt, J Palmer, B Beadle, B Dabaja, H Skinner, G Ibbott, P Balter

Journal

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Ruby - radiation therapy machine

Eve - a beam-agnostic patient positioning system